|
|
||||||||
The Annals of Thoracic Surgery, Vol 55, 413-419, Copyright © 1993 by The Society of Thoracic Surgeons
PW Domkowski, RH Messier Jr, DG Crescenzo, HS Aly, AS Abd-Elfattah, SL Hilbert, RB Wallace and RA Hopkins
To assess the initial metabolic phase of cellular injury from cardiac valve
processing, high-energy phosphate concentrations were analyzed in valve
leaflets subsequent to critical processing steps. Using a porcine model,
valves were processed in a manner identical to human homografts, with 58
randomly assigned to five groups representing distinct preparation phases.
Group I (controls) sustained 40 minutes of warm ischemia concluded by
liquid nitrogen immersion. Remaining groups similarly endured 40 minutes of
ischemia, but were subsequently prepared according to stepwise design: II,
warm ischemia + 24 hours of 4 degrees C ischemia; III, warm ischemia + 24
hours of 4 degrees C antibiotic disinfection; IV, warm ischemia + 24 hours
at 4 degrees C (without antibiotics) + cryopreservation (-1 degrees C/min
cryoprotected freezing); and V, warm
ischemia+disinfection+cryopreservation. At each regimen's conclusion
leaflet extracts were assayed by high-performance liquid chromatography for
high-energy adenine nucleotides (adenosine triphosphate, adenosine
diphosphate, adenosine monophosphate) and catabolites. A 47% and 86%
decrease in cellular adenosine triphosphate level was observed in group III
and group V leaflets, respectively. The level of total adenine nucleotides
was maintained up to cryopreservation; thereafter a 74% decrease was noted.
Catabolite analysis confirmed incomplete degradation of adenine nucleotides
indicating cellular metabolic resilience throughout standard homograft
preparation in valves previously exposed to 40 minutes of warm ischemia.
ARTICLES
Preimplantation alteration of adenine nucleotides in cryopreserved heart valves
Georgetown University School of Medicine, Washington, DC.
This article has been cited by other articles:
![]() |
H. J. Geissler, U. M. Fischer, S. Foerster, A. Krahwinkel, A. Antonyan, A. Kroener, K. Addicks, U. Mehlhorn, and W. Bloch Effect of Thawing on Nitric Oxide Synthase III and Apoptotic Markers in Cryopreserved Human Allografts Ann. Thorac. Surg., November 1, 2006; 82(5): 1742 - 1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Raanani, T. M. Yau, T. E. David, G. Dellgren, B. D. Sonnenberg, and A. Omran Risk factors for late pulmonary homograft stenosis after the Ross procedure Ann. Thorac. Surg., December 1, 2000; 70(6): 1953 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Messier Jr, B. L. Bass, P. W. Domkowski, and R. A. Hopkins INTERSTITIAL CELLULAR AND MATRIX RESTORATION OF CARDIAC VALVES AFTERCRYOPRESERVATION J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 36 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hilbert, R. E. Luna, J. Zhang, Y. Wang, R. A. Hopkins, Z.-X. Yu, and V. J. Ferrans ALLOGRAFT HEART VALVES: THE ROLE OF APOPTOSIS-MEDIATED CELL LOSS J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 454 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Neves, S. Gulbenkian, T. Ramos, A. P. Martins, M. C. Caldas, R. Mascarenhas, M. Guerreiro, A. Matoso-Ferreira, R. Santos, C. Monteiro, et al. MECHANISMS UNDERLYING DEGENERATION OF CRYOPRESERVED VASCULAR HOMOGRAFTS J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1014 - 1021. [Abstract] [Full Text] |
||||
![]() |
C. Wassenaar, W. A. Bax, R.-J. van Suylen, V. D. Vuzevski, and E. Bos EFFECTS OF CRYOPRESERVATION ON CONTRACTILE PROPERTIES OF PORCINE ISOLATED AORTIC VALVE LEAFLETS AND AORTIC WALL J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 165 - 172. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |